Education
About Us
Working with TipRanks
Follow Us
Cbd Life Sciences Inc. (CBDL)
:CBDL
Total Valuation
CBD Life Sciences has a market cap or net worth of $938.49K. The enterprise value is ―.
Market Cap$938.49K
Enterprise Value―
Share Statistics
CBD Life Sciences has 1,876,971,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,876,971,900
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
CBD Life Sciences’s return on equity (ROE) is -0.20 and return on invested capital (ROIC) is -19.91%.
Return on Equity (ROE)-0.20
Return on Assets (ROA)-0.19
Return on Invested Capital (ROIC)-19.91%
Return on Capital Employed (ROCE)-0.20
Revenue Per Employee55.72K
Profits Per Employee-26.19K
Employee Count3
Asset Turnover0.40
Inventory Turnover9.50
Valuation Ratios
The current PE Ratio of CBD Life Sciences is -1.55M. CBD Life Sciences’s PEG ratio is 0.00.
PE Ratio-1.55M
PS Ratio0.00
PB Ratio309.49K
Price to Fair Value309.49K
Price to FCF62.37M
Price to Operating Cash Flow62.37M
PEG Ratio0.00
Income Statement
In the last 12 months, CBD Life Sciences had revenue of 167.15K and earned -78.57K in profits. Earnings per share was 0.00.
Revenue167.15K
Gross Profit-30.60K
Operating Income-78.57K
Pretax Income-78.57K
Net Income-78.57K
EBITDA-23.02K
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -989.00 and capital expenditures 0.00, giving a free cash flow of -989.00 billion.
Operating Cash Flow-989.00
Free Cash Flow-989.00
Free Cash Flow per Share>-0.01
Dividends & Yields
CBD Life Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-94.47
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)552.95K
Important Dates
CBD Life Sciences upcoming earnings date is ―, TBA Not Confirmed.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
CBD Life Sciences as a current ratio of 8.06, with Debt / Equity ratio of 0.00%
Current Ratio8.06
Quick Ratio7.21
Debt to Market Cap0.00
Net Debt to EBITDA0.11
Interest Coverage Ratio0.00
Taxes
In the past 12 months, CBD Life Sciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
CBD Life Sciences EV to EBITDA ratio is -5.31M, with an EV/FCF ratio of 62.37M.
EV to Sales730.61K
EV to EBITDA-5.31M
EV to Free Cash Flow62.37M
EV to Operating Cash Flow62.37M
Balance Sheet
CBD Life Sciences has $82.00 in cash and marketable securities with $0.00 in debt, giving a net cash position of -$82.00 billion.
Cash & Marketable Securities$82.00
Total Debt$0.00
Net Cash-$82.00
Net Cash Per Share>-$0.01
Tangible Book Value Per Share<$0.01
Margins
Gross margin is 29.89%, with operating margin of -47.01%, and net profit margin of -47.01%.
Gross Margin29.89%
Operating Margin-47.01%
Pretax Margin-47.01%
Net Profit Margin-47.01%
EBITDA Margin-13.77%
EBIT Margin-47.01%
Analyst Forecast
The average price target for CBD Life Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―